CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2008-03-10 | Siegel Jordan I Sr. VP Fin. & Admin, CFO Treas | Sale | −100 | $3.26 | $326 | 51,961.19 |
| 2008-03-10 | Siegel Jordan I Sr. VP Fin. & Admin, CFO Treas | Sale | −200 | $3.26 | $652 | 51,761.19 |
| 2008-03-10 | Siegel Jordan I Sr. VP Fin. & Admin, CFO Treas | Sale | −19,012 | $3.26 | $62K | 32,749.19 |
| 2008-03-10 | Siegel Jordan I Sr. VP Fin. & Admin, CFO Treas | Sale | −100 | $3.27 | $327 | 32,649.19 |
| 2008-03-10 | Siegel Jordan I Sr. VP Fin. & Admin, CFO Treas | Sale | −5,095 | $3.27 | $17K | 27,554.19 |
| 2008-03-10 | Siegel Jordan I Sr. VP Fin. & Admin, CFO Treas | Sale | −100 | $3.28 | $328 | 27,454.19 |
| 2008-03-10 | Siegel Jordan I Sr. VP Fin. & Admin, CFO Treas | Sale | −1,000 | $3.28 | $3K | 26,454.19 |
| 2008-03-10 | Siegel Jordan I Sr. VP Fin. & Admin, CFO Treas | Sale | −800 | $3.29 | $3K | 25,654.19 |
| 2008-03-10 | Siegel Jordan I Sr. VP Fin. & Admin, CFO Treas | Sale | −200 | $3.30 | $659 | 25,454.19 |
| 2008-03-10 | Siegel Jordan I Sr. VP Fin. & Admin, CFO Treas | Sale | −100 | $3.30 | $330 | 25,354.19 |
| 2008-03-10 | Siegel Jordan I Sr. VP Fin. & Admin, CFO Treas | Sale | −4,800 | $3.30 | $16K | 20,554.19 |
| 2008-03-10 | Siegel Jordan I Sr. VP Fin. & Admin, CFO Treas | Sale | −100 | $3.31 | $331 | 20,454.19 |
| 2008-03-10 | Siegel Jordan I Sr. VP Fin. & Admin, CFO Treas | Sale | −100 | $3.33 | $333 | 20,354.19 |
| 2008-03-10 | Siegel Jordan I Sr. VP Fin. & Admin, CFO Treas | Sale | −1,100 | $3.33 | $4K | 19,254.19 |
| 2008-03-10 | Siegel Jordan I Sr. VP Fin. & Admin, CFO Treas | Sale | −100 | $3.34 | $334 | 19,154.19 |
| 2008-03-10 | Siegel Jordan I Sr. VP Fin. & Admin, CFO Treas | Sale | −100 | $3.35 | $335 | 19,054.19 |
| 2008-03-10 | Siegel Jordan I Sr. VP Fin. & Admin, CFO Treas | Sale | −897 | $3.50 | $3K | 18,157.19 |
| 2008-03-05 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −30 | $3.78 | $113 | 44,330 |
| 2008-03-05 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −600 | $3.74 | $2K | 43,730 |
| 2008-03-05 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −1,136 | $3.73 | $4K | 42,594 |
Page 37 of 42 · 830 trades